183 related articles for article (PubMed ID: 34581894)
1. Cancer induced bone pain: current management and future perspectives.
Kapoor R; Saxena AK; Vasudev P; Sundriyal D; Kumar A
Med Oncol; 2021 Sep; 38(11):134. PubMed ID: 34581894
[TBL] [Abstract][Full Text] [Related]
2. The Palliative Radiotherapy and Inflammation Study (PRAIS) - protocol for a longitudinal observational multicenter study on patients with cancer induced bone pain.
Habberstad R; Frøseth TCS; Aass N; Abramova T; Baas T; Mørkeset ST; Caraceni A; Laird B; Boland JW; Rossi R; Garcia-Alonso E; Stensheim H; Loge JH; Hjermstad MJ; Bjerkeset E; Bye A; Lund JÅ; Solheim TS; Vagnildhaug OM; Brunelli C; Damås JK; Mollnes TE; Kaasa S; Klepstad P
BMC Palliat Care; 2018 Sep; 17(1):110. PubMed ID: 30266081
[TBL] [Abstract][Full Text] [Related]
3. Bone Metastasis Pain, from the Bench to the Bedside.
Aielli F; Ponzetti M; Rucci N
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30641973
[TBL] [Abstract][Full Text] [Related]
4. Bone Pain in Cancer Patients: Mechanisms and Current Treatment.
Zajączkowska R; Kocot-Kępska M; Leppert W; Wordliczek J
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31801267
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-(1-7)/Mas receptor as an antinociceptive agent in cancer-induced bone pain.
Forte BL; Slosky LM; Zhang H; Arnold MR; Staatz WD; Hay M; Largent-Milnes TM; Vanderah TW
Pain; 2016 Dec; 157(12):2709-2721. PubMed ID: 27541850
[TBL] [Abstract][Full Text] [Related]
6. The cystine/glutamate antiporter system xc- drives breast tumor cell glutamate release and cancer-induced bone pain.
Slosky LM; BassiriRad NM; Symons AM; Thompson M; Doyle T; Forte BL; Staatz WD; Bui L; Neumann WL; Mantyh PW; Salvemini D; Largent-Milnes TM; Vanderah TW
Pain; 2016 Nov; 157(11):2605-2616. PubMed ID: 27482630
[TBL] [Abstract][Full Text] [Related]
7. Bone Pain and Muscle Weakness in Cancer Patients.
Milgrom DP; Lad NL; Koniaris LG; Zimmers TA
Curr Osteoporos Rep; 2017 Apr; 15(2):76-87. PubMed ID: 28497213
[TBL] [Abstract][Full Text] [Related]
8. Clinical and genetic factors related to cancer-induced bone pain and bone pain relief.
Scarpi E; Calistri D; Klepstad P; Kaasa S; Skorpen F; Habberstad R; Nanni O; Amadori D; Maltoni M
Oncologist; 2014 Dec; 19(12):1276-83. PubMed ID: 25342315
[TBL] [Abstract][Full Text] [Related]
9. The Role of Spinal GABAB Receptors in Cancer-Induced Bone Pain in Rats.
Zhou YQ; Chen SP; Liu DQ; Manyande A; Zhang W; Yang SB; Xiong BR; Fu QC; Song ZP; Rittner H; Ye DW; Tian YK
J Pain; 2017 Aug; 18(8):933-946. PubMed ID: 28323246
[TBL] [Abstract][Full Text] [Related]
10. CSF-CN contributes to cancer-induced bone pain via the MKP-1-mediated MAPK pathway.
Chen P; Pan M; Lin QS; Lin XZ; Lin Z
Biochem Biophys Res Commun; 2021 Apr; 547():36-43. PubMed ID: 33592377
[TBL] [Abstract][Full Text] [Related]
11. Neurophysiological mechanisms of cancer-induced bone pain.
Zheng XQ; Wu YH; Huang JF; Wu AM
J Adv Res; 2022 Jan; 35():117-127. PubMed ID: 35003797
[TBL] [Abstract][Full Text] [Related]
12. The Challenges of Managing Bone Pain in Cancer.
Glithero C
Ulster Med J; 2020 Jan; 89(1):7-10. PubMed ID: 32218619
[No Abstract] [Full Text] [Related]
13. Cancer pain relief achieved by disrupting tumor-driven semaphorin 3A signaling in mice.
Maeda T; Yamada D; Kawahara K
Neurosci Lett; 2016 Oct; 632():147-51. PubMed ID: 27592511
[TBL] [Abstract][Full Text] [Related]
14. Proteomic profiling reveals Arl6ip-1 as a candidate target in cancer-induced bone pain rat model after oxycodone treatment.
Deng HS; Xu LS; Ni HD; Wang TT; Liu MJ; Yang MX; Shen H; Pan H; Yao M
Neurosci Lett; 2019 Apr; 699():151-159. PubMed ID: 30708128
[TBL] [Abstract][Full Text] [Related]
15. Management of cancer pain due to bone metastasis.
Takei D; Tagami K
J Bone Miner Metab; 2023 May; 41(3):327-336. PubMed ID: 36418587
[TBL] [Abstract][Full Text] [Related]
16. Sulforaphane alleviates hyperalgesia and enhances analgesic potency of morphine in rats with cancer-induced bone pain.
Fu J; Xu M; Xu L; Ni H; Zhao B; Ni C; Huang M; Zhu J; Luo G; Yao M
Eur J Pharmacol; 2021 Oct; 909():174412. PubMed ID: 34375671
[TBL] [Abstract][Full Text] [Related]
17. miR-300 mitigates cancer-induced bone pain through targeting HMGB1 in rat models.
Liu C; Yang J; Liu H; Xia T; Zhang F
Genes Genomics; 2020 Mar; 42(3):309-316. PubMed ID: 31872385
[TBL] [Abstract][Full Text] [Related]
18. Minimally invasive treatments of painful bone lesions: state of the art.
Barile A; Arrigoni F; Zugaro L; Zappia M; Cazzato RL; Garnon J; Ramamurthy N; Brunese L; Gangi A; Masciocchi C
Med Oncol; 2017 Apr; 34(4):53. PubMed ID: 28236103
[TBL] [Abstract][Full Text] [Related]
19. The therapeutic potential of GABA in neuron-glia interactions of cancer-induced bone pain.
Ge MM; Chen SP; Zhou YQ; Li Z; Tian XB; Gao F; Manyande A; Tian YK; Yang H
Eur J Pharmacol; 2019 Sep; 858():172475. PubMed ID: 31228456
[TBL] [Abstract][Full Text] [Related]
20. Spinal SET7/9 may contribute to the maintenance of cancer-induced bone pain in mice.
Hang LH; Xu ZK; Wei SY; Shu WW; Luo H; Chen J
Clin Exp Pharmacol Physiol; 2017 Oct; 44(10):1001-1007. PubMed ID: 28557056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
